After Trump Tariff Pledge, Swiss Pharma Company Announces $23 Billion Investment in US

/0 Comments/in , /by

Swiss pharmaceutical company Novartis will build seven new facilities in the United States, as well as expand others, in a $23 billion investment over five years.

This development comes after President Trump’s announcing the implementation of tariffs on imported drugs.

Novartis announced the investment in a press release.

“This commitment enables Novartis to expand on its current manufacturing, research and technology presence across the country with 10 facilities, including 7 brand new facilities, creating nearly 1,000 new jobs at Novartis and approximately 4,000 additional US jobs,” it stated. (Read more from “After Trump Tariff Pledge, Swiss Pharma Company Announces $23 Billion Investment in US” HERE)